Dermapharm Holding SE (DMP) — Working Capital to Net Assets Ratio
Dermapharm Holding SE (DMP) has a Working Capital to Net Assets ratio of 51.3% as of December 2025. Working capital of €360.00 Million (current assets of €702.92 Million minus current liabilities of €342.93 Million) is measured against net assets of €701.83 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of Dermapharm Holding SE to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Dermapharm Holding SE Working Capital to Net Assets (2013–2025)
This chart shows how Dermapharm Holding SE's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the ratio stands at 51.3%, reflecting working capital of €360.00 Million against net assets of €701.83 Million EUR. Check DMP tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Dermapharm Holding SE (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Dermapharm Holding SE from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Dermapharm Holding SE.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 51.3% | €360.00 Million | €701.83 Million | €702.92 Million | €342.93 Million | ▲ +7.5 pp |
| 2024 | 43.8% | €266.58 Million | €608.29 Million | €593.50 Million | €326.92 Million | ▲ +0.5 pp |
| 2023 | 43.3% | €236.01 Million | €545.05 Million | €630.50 Million | €394.49 Million | ▼ -16.1 pp |
| 2022 | 59.4% | €316.15 Million | €532.49 Million | €533.95 Million | €217.79 Million | ▼ -13.4 pp |
| 2021 | 72.7% | €363.61 Million | €499.83 Million | €519.22 Million | €155.61 Million | ▼ -9.6 pp |
| 2020 | 82.3% | €267.18 Million | €324.58 Million | €400.05 Million | €132.87 Million | ▼ -5.7 pp |
| 2019 | 88.1% | €250.52 Million | €284.49 Million | €352.94 Million | €102.42 Million | ▲ +0.3 pp |
| 2018 | 87.8% | €224.84 Million | €256.08 Million | €371.24 Million | €146.40 Million | ▼ -64.6 pp |
| 2017 | 152.4% | €112.29 Million | €73.69 Million | €192.87 Million | €80.58 Million | ▲ +84.1 pp |
| 2016 | 68.3% | €41.54 Million | €60.81 Million | €156.96 Million | €115.42 Million | ▼ -112.9 pp |
| 2015 | 181.2% | €80.53 Million | €44.44 Million | €142.10 Million | €61.57 Million | ▼ -29.0 pp |
| 2014 | 210.2% | €71.50 Million | €34.01 Million | €168.54 Million | €97.04 Million | ▲ +178.2 pp |
| 2013 | 32.0% | €13.24 Million | €41.36 Million | €181.90 Million | €168.66 Million | — |